What is Pacemate?
Pacemate operates as a specialized healthcare technology provider, delivering a sophisticated cardiac device monitoring platform. The company serves as a critical bridge for integrated delivery networks and academic health systems, offering a unified digital interface that aggregates data from disparate device manufacturers and electronic health records. By streamlining clinical workflows and enhancing patient oversight, Pacemate addresses the growing demand for interoperable, intelligent health solutions in an increasingly fragmented medical device market. Its platform is engineered to improve operational efficiency while maintaining high standards of patient care, positioning the firm as a vital partner for large-scale medical institutions.
How much funding has Pacemate raised?
Pacemate has raised a total of $8M across 1 funding round:
Series A
$8M
Series A (2021): $8M with participation from Ballast Point Ventures LP
Key Investors in Pacemate
Ballast Point Ventures LP
A growth-oriented venture capital firm that focuses on providing capital and strategic support to rapidly expanding companies in the healthcare and technology sectors.
What's next for Pacemate?
With the recent influx of capital, Pacemate is well-positioned to accelerate its product development roadmap and expand its footprint across major health systems. The strategic focus will likely center on deepening the integration capabilities of its platform and enhancing the predictive analytics features that support clinical decision-making. As the healthcare sector continues to prioritize digital transformation and remote patient monitoring, Pacemate is poised to leverage its current momentum to capture additional market share. Future growth will depend on the company's ability to maintain its technological edge while navigating the rigorous regulatory and security requirements inherent in the cardiac monitoring space.
See full Pacemate company page
